Kuwait Ministry of Health stockpiles thyroid-blocking potassium iodide for nuclear radiation emergencies
MOORESVILLE, N.C., Jan. 22 /PRNewswire/ -- Nukepills.com today announced the sale of 180,000 units (5.4 million doses) of ThyroShield(TM) Potassium Iodide to the Kuwait Ministry of Health. Worth approximately $1.4 million, the sale was brokered by Nukepills.com and signifies Kuwait's proactive course in protecting its citizens during a nuclear radiation emergency.
"This sale is the first large-scale order of ThyroShield from a foreign government. We are currently working on additional potassium iodide orders from other countries in the Middle East, Europe and Asia. We hope the new U.S. administration follows Kuwait's lead and reinstitutes the potassium iodide distribution plan to protect its citizens," said Troy Jones, President of Nukepills.com.
ThyroShield(TM) Potassium Iodide Oral Solution is a ready-to-use, thyroid-blocking liquid medicine for radiation emergencies. Stockpiling of potassium iodide is recommended by health officials worldwide to prevent thyroid cancer in those exposed to radioactive iodine in the event of a nuclear reactor accident or fallout from a nuclear weapon. Potassium iodide protects against the harmful effects of radioactive iodine by preventing its absorption by the thyroid gland. Thyroid cells are the only cells in the human body that can absorb iodine, and are thus the only cells at risk for cancer. ThyroShield(TM) is manufactured by Fleming Pharmaceuticals of Fenton, Missouri.
Nukepills.com is an Internet-based supplier of radiation emergency products that protect against dirty bomb radiation, nuclear reactor accidents and nuclear weapon fallout, and are used for radiation therapy/decontamination in hospitals. Since 1999, Nukepills.com has sold directly to the general public, businesses, and government agencies worldwide and is also the largest Internet distributor of Iosat(TM) Potassium Iodide, an FDA-approved, full-strength tablet. Last year, Nukepills.com added the credit-card-sized RADTriage(TM) Personal Radiation Detector to its product line and expects Government Emergency Preparedness grants and civilian orders to continue to drive sales of all its products in 2009.
Contact: Troy Jones, President Nukepills.com Ph: 866-283-3986 email@example.com 631 Brawley School Rd STE 407 Mooresville, NC 28117 http://www.nukepills.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
Copyright©2009 PR Newswire.
All rights reserved